Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (19 ops.)
Latest filing published 17 Oct 2013 for SAVIENT PHARMACEUTICALS INC, €623.
Insider track record
Disclosed buys
1
Disclosed sells
19
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Richard CROWLEY: trading record in brief
Richard CROWLEY has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Imclone Systems Inc/de and Savient Pharmaceuticals Inc. The record holds 35 filings, for trades running from 21 April 2006 to 15 October 2013.
On the open market, the record shows 1 purchase worth €5,610 and 19 sales worth €2.8M. Netting one side against the other leaves €2.8M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants and 11 option exercises. So far in 2013, the count stands at no purchases and 6 sales.
The record was last updated on 17 October 2013 with an open-market sale (€623) in Savient Pharmaceuticals Inc. The last insider purchase was made public on 22 November 2011, 5,449 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard CROWLEY
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
11,165 shares@ US$0.0755Common StockSEC:0001181431-13-054157:0
102,575 shares@ US$0.076Common StockSEC:0001181431-13-054157:1
2,485 shares@ US$0.74Common StockSEC:0001181431-13-024354:0
18,900 shares@ US$1.01Common Stock $.01 par value per shareSEC:0001181431-13-007057:0
30,000 shares@ US$1.05Common Stock $.01 par value per shareSEC:0001181431-13-007057:1
2,415 shares@ US$1.02Common Stock $.01 par value per shareSEC:0001181431-13-006299:0
2,010 shares@ US$1.45Common Stock, $.01 par value per shareSEC:0001181431-12-057115:0
2,500 shares@ US$0.62Common Stock, $.01 par value per shareSEC:0001181431-12-043397:0
9,200 shares@ US$2.35Common Stock, $.01 par value per shareSEC:0001181431-12-026762:0
250,000 shares@ US$2.26Common Stock, $.01 par value per shareSEC:0001181431-12-007986:0
3,000 shares@ US$2.53Common Stock, $.01 par value per shareSEC:0001181431-11-057427:0
Canonical exit: 19 Feb 2012 (T+90)
100,000 shares@ US$11.62Common Stock, $.01 par value per shareSEC:0001181431-11-026542:0
1,774 shares@ US$70.00Common StockSEC:0001104659-08-072713:0
11,957 shares@ US$27.94COMMON STOCKSEC:0001104659-08-069272:0
11,957 shares@ US$68.72COMMON STOCKSEC:0001104659-08-069272:1
11,957 shares@ US$27.94COMMON STOCKSEC:0001104659-08-056889:0
11,957 shares@ US$64.40COMMON STOCKSEC:0001104659-08-056889:1
15,000 shares@ US$31.81COMMON STOCKSEC:0001104659-08-049255:0
15,000 shares@ US$64.16COMMON STOCKSEC:0001104659-08-049255:1
11,957 shares@ US$27.94COMMON STOCKSEC:0001104659-08-049255:2
11,957 shares@ US$64.16COMMON STOCKSEC:0001104659-08-049255:3
2,667 shares0COMMON STOCKSEC:0001104659-08-011788:0
893 shares@ US$39.06COMMON STOCKSEC:0001104659-08-011788:1
6,000 shares@ US$6.94COMMON STOCKSEC:0001104659-07-084555:0
6,000 shares@ US$42.65COMMON STOCKSEC:0001104659-07-084555:1
25 of 35 declarations
